BUHLMANN Diagnostics Corp

BUHLMANN Diagnostics Corp is a clinical laboratory diagnostic company specializing in immunoassay and biochemical testing solutions. The company manufactures and distributes FDA-cleared in vitro diagnostic (IVD) assays across multiple therapeutic and diagnostic areas including gastroenterology, autoimmunity, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. Core product lines include calprotectin assays (BÜHLMANN fCAL® turbo and ELISA), pancreatic elastase (BÜHLMANN fPELA® turbo), Quantum Blue® point-of-care and laboratory immunoassay systems, Flow CAST® and CAST® ELISA for allergy testing, and neuroimmunology assays for peripheral neuropathy detection (GanglioCombi® MAG and anti-ganglioside antibody tests). The company offers random-access turbidimetric immunoassays, ELISA-based methods, and extraction technologies (CALEX® Cap) for improved analytical stability and laboratory workflow automation. FDA clearance is documented for multiple products including fCAL® turbo, fCAL® ELISA, fPELA® turbo, ACE KINETIC, and CIC-C1q ELISA. BUHLMANN serves clinical laboratories, hospital pathology departments, gastroenterology centers, and specialty diagnostic facilities. The organization maintains quality management systems and actively participates in medical and scientific conferences (e.g., DDW 2026). Support includes technical customer service, FAQs, and product-specific literature.